
Results
11
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
11 companies
AddLife
Market Cap: SEK 18.9b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 157.80
7D
10.7%
1Y
-19.8%
Bonesupport Holding
Market Cap: SEK 14.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 230.80
7D
7.6%
1Y
-12.8%
Swedencare
Market Cap: SEK 4.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 27.05
7D
2.1%
1Y
-38.5%
Devyser Diagnostics
Market Cap: SEK 1.6b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 92.80
7D
-2.5%
1Y
-18.0%
Cinclus Pharma Holding
Market Cap: SEK 573.3m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 12.02
7D
-0.3%
1Y
-32.3%
Mendus
Market Cap: SEK 312.9m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 5.18
7D
-0.4%
1Y
-0.4%
Promimic
Market Cap: SEK 207.8m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 10.50
7D
-13.2%
1Y
-43.2%
Diamyd Medical
Market Cap: SEK 172.7m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 1.13
7D
-0.2%
1Y
-88.9%
IDL Diagnostics
Market Cap: SEK 115.0m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.49
7D
0.8%
1Y
-9.3%
Alzinova
Market Cap: SEK 71.2m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.44
7D
0.3%
1Y
-72.7%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%